1. Home
  2. CLWT vs CANF Comparison

CLWT vs CANF Comparison

Compare CLWT & CANF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CLWT
  • CANF
  • Stock Information
  • Founded
  • CLWT 1971
  • CANF 1994
  • Country
  • CLWT Hong Kong
  • CANF Israel
  • Employees
  • CLWT N/A
  • CANF N/A
  • Industry
  • CLWT Professional and commerical equipment
  • CANF Biotechnology: Pharmaceutical Preparations
  • Sector
  • CLWT Consumer Discretionary
  • CANF Health Care
  • Exchange
  • CLWT Nasdaq
  • CANF Nasdaq
  • Market Cap
  • CLWT 9.4M
  • CANF 9.6M
  • IPO Year
  • CLWT 1997
  • CANF N/A
  • Fundamental
  • Price
  • CLWT $1.22
  • CANF $0.44
  • Analyst Decision
  • CLWT
  • CANF Strong Buy
  • Analyst Count
  • CLWT 0
  • CANF 2
  • Target Price
  • CLWT N/A
  • CANF $14.50
  • AVG Volume (30 Days)
  • CLWT 68.2K
  • CANF 287.3K
  • Earning Date
  • CLWT 01-01-0001
  • CANF 11-27-2025
  • Dividend Yield
  • CLWT N/A
  • CANF N/A
  • EPS Growth
  • CLWT N/A
  • CANF N/A
  • EPS
  • CLWT 0.10
  • CANF N/A
  • Revenue
  • CLWT $15,383,000.00
  • CANF $560,000.00
  • Revenue This Year
  • CLWT N/A
  • CANF $461.72
  • Revenue Next Year
  • CLWT N/A
  • CANF N/A
  • P/E Ratio
  • CLWT $12.83
  • CANF N/A
  • Revenue Growth
  • CLWT N/A
  • CANF N/A
  • 52 Week Low
  • CLWT $1.01
  • CANF $0.46
  • 52 Week High
  • CLWT $1.63
  • CANF $2.55
  • Technical
  • Relative Strength Index (RSI)
  • CLWT 41.94
  • CANF 25.97
  • Support Level
  • CLWT $1.22
  • CANF $0.46
  • Resistance Level
  • CLWT $1.27
  • CANF $0.49
  • Average True Range (ATR)
  • CLWT 0.04
  • CANF 0.03
  • MACD
  • CLWT -0.01
  • CANF -0.00
  • Stochastic Oscillator
  • CLWT 8.90
  • CANF 3.76

About CLWT Euro Tech Holdings Company Limited

Euro Tech Holdings Co Ltd is a distributor and manufacturer of technology instruments as well as an environmental engineering services provider. It is engaged in the marketing and trading of water and wastewater related process control, analytical and testing instruments, disinfection equipment, supplies, and related automation systems. There are two operating segments of the company. The Trading and manufacturing segment, which is the key revenue driver, includes distribution of water treatment equipment, laboratory instruments, analyzers, test kits, and related supplies and power generation equipment. The Engineering segment includes water and waste-water treatment engineering and air pollution control business. The majority of the revenue is generated from Hong Kong.

About CANF Can-Fite Biopharma Ltd Sponsored ADR (Israel)

Can Fite Biofarma Ltd is an clinical-stage biopharmaceutical company. The company develops orally bioavailable small molecule therapeutic products for the treatment of cancer, liver and inflammatory diseases and erectile dysfunction. The company's platform technology utilizes the Gi protein associated A3 adenosine receptor, or A3AR, as a therapeutic target. The company's drug candidate, Piclidenoson, is currently in a Phase III trial for psoriasis. Can-Fite's liver drug, Namodenoson, is headed into a Phase III trial for hepatocellular carcinoma (HCC), the common form of liver cancer, and a Phase IIb trial for the treatment of non-alcoholic steatohepatitis (NASH).

Share on Social Networks: